Treatments for co-occurring depression and substance use in young people: A systematic review

Current Drug Abuse Reviews

Volumn 7, Issue 1, 2014, Pages 3-17

  Deady, Mark ^a,b   Teesson, Maree ^a,b   Kay Lambkin, Frances J ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NHMRC Centre of Research Excellence in Mental Health and Substance Use   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Adolescent; Alcohol; Co occurring disorder; Comorbidity; Depression; Substance use; Systematic review; Young people

Indexed keywords

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITATIVE RESEARCH; RISK ASSESSMENT; SUBSTANCE USE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; COMPLICATION; COUNSELING; DEPRESSIVE DISORDER, MAJOR; MULTIMODALITY CANCER THERAPY; PSYCHIATRIC DIAGNOSIS; SUBSTANCE-RELATED DISORDERS;

COMBINED MODALITY THERAPY; COUNSELING; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84925845170     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473707666141015220608     Document Type: Article

References (169)

1. [1] Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCSA). J Am Acad Child Adolesc Psychiatry 2010; 49(10): 980-9.
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6): 593-602.
3. ABS. National Survey Mental Health and Wellbeing: Summary of Results, 2007. Canberra: Australian Bureau of Statistics 2008 4326.0.
4. Grant BF, Hasin DS, Dawson DA. The relationship between DSM- IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample. J Affect Disord 1996; 38(2-3): 113-28.
5. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co- occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 807-16.
6. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry 2006; 163: 2141-7.
7. [7] Berkson J. Limitations of the application of 4-fold tables to hospital data. Biom Bull 1946; 2: 47-53.
8. [8] Kaminer Y, Bukstein O. Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors. New York: Haworth Press 2007.
9. [9] Chan Y-F, Dennis ML, Funk RR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat 2008; 34(1): 14-24.
10. [10] Kaminer Y, Burleson JA, Goldberger R. Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. J Nerv Ment Dis 2002; 190(11): 737-45.
11. [11] Bukstein OG, Glancy L, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 1992; 31: 1041-5.
12. [12] Baker KD, Lubman DI, Cosgrave EM, et al. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment. Aust N Z J Psychiatry 2007; 41: 896-902.
13. [13] Kramer T, Robbins J, Phillips S, Miller T, Burns B. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry 2003; 42: 1318-26.
14. [14] Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, et al. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005; 87(1): 43-55.
15. [15] Sher L. Risk and protective factors for suicide in patients with alcoholism. TheScientificWorld J 2006; 6: 1405-11.
16. [16] Esposito-Smythers C, Spirito A. Adolescent substance use and suicidal behavior: A review with implications for treatment research. Alcohol Clin Exp Res 2004; 28(5 SUPPL.): 77S-88S.
17. [17] Sher L, Zalsman G. Alcohol and adolescent suicide. Int J Adolesc Med Health 2005; 17(3): 197-203.
18. [18] Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4(10): 819-28.
19. [19] Dumais A, Lesage AD, Alda M, et al. Risk factors for suicide completion in major depression: A case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry 2005; 162: 2116-24.
20. [20] Sher L, Oquendo M, Galfalvy H, et al. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism. Addict Behav 2005; 30: 1144-53.
21. [21] Sher L, Oquendo MA, Richardson-Vejlgaard R, et al. Effect of acute alcohol use on the lethality of suicide attempts in patients with mood disorders. J Psychiatr Res 2009; 43(10): 901-5.
22. [22] Davis LL, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008; 21(1): 14-8.
23. [23] Davis LL, Frazier E, Husain M, et al. Substance use disorder comorbidity in major depressive disorder: A confirmatory analysis of the STAR*D cohort. Am J Addict 2006; 15(4): 278-85.
24. [24] Sullivan LE, Fiellin DA, O'Connor PG. The prevalence and impact of alcohol problems in major depression: A systematic review. Am J Med 2005; 118(4): 330-41.
25. [25] Lubman DI, Allen NB, Rogers N, Cementon E, Bonomo Y. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord 2007; 103(1-3): 105-12.
26. [26] Tomlinson KL, Brown SA, Abrantes A. Psychiatric comorbidity and substance use treatment outcomes of adolescents. Psychol Addict Behav 2004; 18(2): 160-9.
27. [27] Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry 2003; 160: 890-5.
28. [28] Erfan S, Hashim AH, Shaheen M, Sabry N. Effect of comorbid depression on substance use disorders. Subst Abus 2010; 31(3): 162-9.
29. [29] Cornelius JR, Maisto SA, Martin CS, et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav 2004; 29(5): 1035-8.
30. Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. J Subst Abuse Treat 2005; 28: 189-96.
31. [31] Sayre SL, Schmitz JM, Stotts AL, Averill PM, Rhoades HM, Grabowski JJ. Determining predictors of attrition in an outpatient substance abuse program. Am J Drug Alcohol Abuse 2002; 28(1): 55-72.
32. [32] Gilbert M, Fine S, Haley G. Factors associated with dropout from group psychotherapy with depressed adolescents. Can J Psychiatry 1994; 39(6): 358-9.
33. [33] Agosti V, Nunes E, Stewart JW, Quitkin FM. Patient factors Related to early attrition from an outpatient cocaine research clinic: A preliminary report. Int J Addict 1991; 26(3): 327-34.
34. [34] Khantzian EJ. The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harv Rev Psychiatry 1997; 4(5): 231-44.
35. [35] Bolton JM, Robinson J, Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 2009; 115: 367-75.
36. [36] Mark TL. The costs of treating persons with depression and alcoholism compared with depression alone. Psychiatr Serv 2003; 54: 1095-7.
37. [37] Curran GM, Sullivan G, Williams K, et al. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med 2003; 41: 659-67.
38. [38] Curran GM, Sullivan G, Williams K, Han X, Allee E, Kotrla KJ. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: An observational cohort study. BMC Emerg Med 2008; 8: 17.
39. [39] O’Toole TP, Pollini R, Gray P, Jones T, Bigelow G, Ford DE. Factors identifying high-frequency and low-frequency health service utilization among substance-using adults. J Subst Abuse Treat 2007; 33: 51-9.
40. [40] Hoff RA, Rosenheck RA. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Med Care 1998; 36: 835-43.
41. [41] Hoff RA, Rosenheck RA. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatr Serv 1999; 50: 1309-15.
42. [42] Roberts AR, Corcoran K. Adolescents growing up in stressful environments, dual diagnosis, and sources of success. Brief Treat Crisis Interv 2005; 5: 1-8.
43. [43] Kay-Lambkin FJ, Baker A, Carr VJ. Depression and drug and alcohol problems. In: A. Baker, Velleman R, editors. Clinical Handbook of co-existing mental health and drug and alcohol problems. London: Routledge 2007.
44. [44] Kavanagh DJ. Psychological management of substance misuse in people with mental disorder. Kelvin Grove: Queensland University of Technology 2008.
45. [45] Kavanagh DJ, Mueser KT. Current evidence on integrated treatment for serious mental disorder and substance misuse. J Norwegian Psychol Assoc 2007; 44: 618-37.
46. [46] Watkins KE, Paddock SM, Zhang L, Wells KB. Improving care for depression in in-patients with comorbid substance misuse. Am J Psychiatry 2006; 163: 125-32.
47. [47] Baker A, Kavanagh DJ, Kay-Lambkin FJ, et al. Randomized controlled trial of cognitive–behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction 2010; 105(1): 87-99.
48. [48] Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction 2009; 104(3): 378-88.
49. [49] Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37(1): 11-24.
50. [50] Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial. JAMA 2012; 308(7): 690-9.
51. [51] Lydecker KP, Tate SR, Cummins KM, McQuaid J, Granholm E, Brown SA. Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychol Addict Behav 2010; 24(3): 453-65.
52. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004; 291(15): 1887-96.
53. Horsfall J, Cleary M, Hunt GE, Walter G. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): A review of empirical evidence. Harv Rev Psychiatry 2009; 17: 24-34.
54. Riggs PD, Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J Am Acad Child Adolesc Psychiatry 2002; 41(10): 1253-5.
55. Libby AM, Riggs PD. Integrated substance use and mental health treatment for adolescents: Aligning organizational and financial incentives. J Child Adolesc Psychopharmacol 2005; 15(5): 826-34.
56. Kavanagh DJ, Baker A, Teesson M. Co-morbidity of mental disorders and substance misuse: introduction. Drug Alcohol Rev 2004; 23: 405-6.
57. Dumaine ML. Meta-analysis of interventions with co-occurring disorders of severe mental illness and substance abuse: Implications for social work practice. Res Social Work Prac 2003; 13: 142-65.
58. Cleary M, Hunt GE, Matheson S, Walter G. Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review. J Adv Nurs 2009; 65(2): 238-58.
59. Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 2009; 9: e6.
60. Shrier LA, Harris SK, Kurland M, Knight JR. Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics 2003; 111(6 Pt 1): e699-705.
61. McGorry P. Should youth mental health become a specialty in its own right? Yes. Br Med J 2009; 339: b3373.
62. Burgess PM, Pirkis JE, Slade TN, Johnston AK, Meadows GN, Gunn JM. Service use for mental health problems: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009; 43(7): 615-23.
63. Reavley NJ, Cvetkovski S, Jorm AF, Lubman DI. Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2010; 44(8): 729-35.
64. Keyes KM, Hatzenbuehler ML, McLaughlin KA, et al. Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol. 2010. Epub November 2, 2010.
65. Teesson M, Hall W, Slade T, et al. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction 2010; 105(12): 2085-94.
66. Coyle JT, Pine DS, Charney DS, et al. Depression and Bipolar Support Alliance Consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry 2003; 42(12): 1494-503.
67. Link BG, Struening EL, Rahav M, Phelan JC, Nuttbrock L. On Stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav 1997; 38(2): 177-90.
68. Wagner EF, Brown SA, Monti PM, Myers MG, Waldron HB. Innovations in adolescent substance abuse intervention. Alcohol Clin Exp Res 1999; 23(2): 236-49.
69. Griffin KW, Botvin GJ, Epstein JA, Doyle MM, Diaz T. Psychosocial and behavioral factors in early adolescence as predictors of heavy drinking among high school seniors. Journal of Studies on Alcohol and Drugs 2000; 61: 603-6.
70. Beal AC, Ausiello J, Perrin JM. Social influences on health-risk behaviors among minority middle school students. J Adolesc Health 2001; 28(6): 474-80.
71. Singh SP. Transition of care from child to adult mental health services: the great divide. Curr Opin Psychiatry 2009; 22: 386-90.
72. Parry-Jones W. The future of adolescent psychiatry. Br J Psychiatry 1995; 166: 299-305.
73. Pottick K, Bilder S, Vander Stoep A, Warner L, Alvarez M. US patterns of mental health service utilization for transition-age youth and young adults. Journal of Behavioral Health Services and Research 2008; 35(4): 373-89.
74. Tonin V. Young people seeking mental health care. Lancet 2007; 369: 1239-40.
75. Rickwood DJ, Deane FP, Wilson CJ. When and how do young people seek professional help for mental health problems? Med J Aust 2007; 187(7 suppl): S35-9.
76. Schwartz SJ, Cote JE, Arnett JJ. Identity and agency in emerging adulthood: Two developmental routes in the individualization process. Youth Soc 2005; 37(2): 201-29.
77. McDermott B, Baigent M, Chanen A, et al. Clinical practice guidelines: Depression in adolescents and young adults. Melbourne: beyondblue: the national depression initiative 2010.
78. Winters KC. Treating Adolescents with Substance Use Disorders: An Overview of Practice Issues and Treatment Outcome. Subst Abus 1999; 20(4): 203-25.
79. Masten AS, Burt KB, Roisman GI, Obradović J, Long JD, Tellegen A. Resources and resilience in the transition to adulthood: continuity and change. Dev Psychopathol 2004; 16(4): 1071-94.
80. Deas D, Riggs P, Langenbucher J, Goldman M, Brown S. Adolescents are not adults: Developmental considerations in alcohol users. Alcohol Clin Exp Res 2000; 24(2): 232-7.
81. Sawyer MG, Arney FM, Baghurst PA, et al. The mental health of young people in Australia: Key findings from the child and adolescent component of the National Survey of Mental Health and Well-Being. Aust N Z J Psychiatry 2001; 35(6): 806-14.
82. Bender K, Springer DW, Kim JS. Treatment effectiveness with dually diagnosed adolescents: A systematic review. Brief Treat Crisis Interv 2006; 6(3): 177-205.
83. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: American Psychiatric Association 1994.
84. Riosa PB, McArthur BA, Preyde M. Effectiveness of psychosocial intervention for children and adolescents with comorbid problems: A systematic review. J Child Adolesc Ment Health 2011; 16(4): 177-85.
85. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration 2011. Available from: www.cochrane-handbook.org.
86. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 2009; 6(7): e1000100.
87. Curry JF, Wells KC, Lochman JE, Craighead WE, Nagy PD. Cognitive-behavioral intervention for depressed, substance-abusing adolescents: Development and pilot testing. J Am Acad Child Adolesc Psychiatry 2003; 42(6): 656-65.
88. Kaminer Y, Burleson JA, Blitz C, Sussman J, Rounsaville BJ. Psychotherapies for adolescent substance abusers: A pilot study. J Nerv Ment Dis 1998; 186(11): 684-90.
89. Kaminer Y, Burleson JA. Psychotherapies for adolescent substance abusers: 15-month follow-up of a pilot study. Am J Addict 1999; 8(2): 114-9.
90. Pressman M, Brook DW, Maidman P, Orlowski B. Clinical improvement in adolescents comorbid for substance abuse and psychiatric diagnoses through multiple group psychotherapy. Group 2001; 25(4): 321-32.
91. Cleminshaw HK, Shepler R, Newman I. The Integrated Co-Occurring Treatment (ICT) Model: A promising practice for youth with mental health and substance abuse disorders. J Dual Diagn 2005; 1(3): 85-94.
92. Jenson JM, Potter CC. The effects of cross-system collaboration on mental health and substance abuse problems of detained youth. Res Social Work Prac 2003; 13(5): 588-607.
93. Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB. Fluoxetine in Depressed AUD Adolescents: A 1-Year Follow-up Evaluation. J Child Adolesc Psychopharmacol 2004; 14(1): 33-8.
94. Cornelius JR, Clark DB, Bukstein OG, et al. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder a five-year follow-up study. J Dual Diagn 2006; 2(1): 11-25.
95. Cornelius JR, Clark DB, Bukstein OG, Birmaher B, Salloum IM, Brown SA. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review. Addict Behav 2005; 30(9): 1824-33.
96. Cornelius JR, Clark DB, Bukstein OG, Kelly TM, Salloum IM, Wood DS. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: A 3-year follow-up study. Addict Behav 2005; 30(4): 807-14.
97. Curry JF, Wells KC, Lochman JE, Craighead WE, Nagy PD. Group and family cognitive behavior therapy for adolescent depression and substance abuse: A case study. Cogn Behav Pract 2001; 8(4): 367-76.
98. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. Fluoxetine in drug-dependent delinquents with major depression: An open trial. J Child Adolesc Psychopharmacol 1997; 7(2): 87-95.
99. Hamilton Effective Public Health Practice Project Team. Dictionary for the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies. Hamilton: Effective Public Health Practice Project, 2003.
100. Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: Providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004; 1(3): 176-84.
101. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment tool: methodological research. J Eval Clin Pract 2012; 18(1): 12-8.
102. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates 1988.
103. Walter SD, Yao X. Effect sizes can be calculated for studies reporting ranges for outcome variables in systematic reviews. J Clin Epidemiol 2007; 60(8): 849-52.
104. Morris SB. Estimating effect sizes from pretest-posttest-control group designs. Org Res Methods 2008; 11(2): 364-86.
105. Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods 2002; 7(1): 105-25.
106. Becker BJ. Synthesizing standardized mean-change measures. Br J Math Stat Psychol 1988; 41: 257-78.
107. Morris SB. Distribution of the standardized mean change effect size for meta-analysis on repeated measures. Br J Math Stat Psychol 2000; 53: 17-29.
108. Hides LM, Carroll S, Catania L, et al. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people. J Affect Disord 2010; 121(1-2):169-74.
109. Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, et al. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial. Addict Behav 2001; 26(5): 735-9.
110. Findling RL, Pagano ME, McNamara NK, et al. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: A pilot randomized placebo-controlled trial. Child Adolesc Psychiatry Ment 2009; 3: e11.
111. Cornelius JR, Bukstein OG, Douaihy AB, et al. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend 2010; 112(1-2): 39-45.
112. Cornelius JR, Bukstein OG, Wood DS, Kirisci L, Douaihy A, Clark DB. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addict Behav 2009; 34(10): 905-9.
113. Cornelius JR, Douaihy A, Bukstein OG, et al. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addict Behav 2011; 36(8): 843-8.
114. Hides LM, Elkins KS, Scaffidi A, Cotton SM, Carroll S, Lubman DI. Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse? Med J Aust 2011; 195(3 SUPPL.): S31-S7.
115. Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: A pilot study. Hum Psychopharmacol 2000; 15(6): 461-9.
116. Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med 2007; 61(11): 1026-34.
117. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003; 60(2): 84-9.
118. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition. New York: Biometrics Research, New York State Psychiatric Institute. 2001.
119. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press. 1990.
120. Chambers W, Puig-Antich J, Hirsch M, et al. The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry 1985; 42(7): 696-702.
121. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K- SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-8.
122. Shaffer D. NIMH Diagnostic Interview Schedule for Children-Version IV. New York: New York State Psychiatric Institute 1997.
123. Angold A, Costello EJ. The Child and Adolescent Psychiatric Assessment (CAPA). J Am Acad Child Adolesc Psychiatry 2000; 39(1): 39-48.
124. Cottler L, Robins L, Helzer J. The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict 1989; 84(7): 801-14.
125. Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 1988; 83: 393-402.
126. Curry JF, Wells K. Recent Recall Form. Durham, NC: Duke University; 1997.
127. Saunders JB, Aasland OG, Babor TF, Fuente JRdl, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 1993; 88: 791-804.
128. Gossop M, Darke S, Griffiths P, et al. The severity of dependence scale (sds):psychometric properties of the sds in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607-14.
129. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
130. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
131. Kovacs M. Children’s Depression Inventory Manual. North Tonawanda, NY: Multi-Health Systems 1992.
132. Watson D, Weber K, Assenheimer J, Clark L, Strauss M, McCormick R. Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 1995; 104(1): 3-14.
133. Poznanski E, Freeman L, Mokros H. Children's depression rating scale - revised. Psychopharmacol Bull 1985; 21: 979-89.
134. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol 1977; 1: 385-401.
135. NIMH. Clinical Global Impressions Scale. Psychopharmacol Bull 1985; 21: 839-43.
136. Shaffer D, Gould M, Brasic J, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983; 40: 1228-31.
137. Heather N, Rollnick S. Readiness to Change Questionnaire: User’s Manual. Centre for Alcohol & Drug Studies: Newcastle, UK 2000.
138. Hollan S, Kendall P. Cognitive self-statements in depression: development of an Automatic Thoughts Questionnaire. Cogn Ther Res 1980; 4: 383-95.
139. Mueser KT, Pallavi N, Tracy JI, DeGirolamo J, Molinaro M. Expectations and motives for substance use in schizophrenia. Schizophr Bull 1995; 21: 367-78.
140. Endler NS, Parker JD. Assessment of multidimensional coping: task, emotion, and avoidance strategies. Psychol Assess 1994; 6: 50-60.
141. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psychiatr Scand 2000; 101(4): 323-9.
142. Weisman AN, Beck AT. Development and Validation of the Dysfunctional Attitudes Scale: a Preliminary Investigation. Toronto, Canada: The American Education Research Association 1978.
143. Clark DB, Donovan JE. Reliability and validity of the Hamilton Anxiety Rating Scale in an adolescent sample. J Am Acad Child Adolesc Psychiatry 1994; 33: 354-60.
144. Kessler RC. Kessler's 10 Psychological Distress Scale. Boston, MA: Harvard Medical School 1996.
145. Lehman A. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988; 11: 51-62.
146. Beck A, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42: 861-5.
147. Bukstein OG, Horner MS. Management of the Adolescent with Substance Use Disorders and Comorbid Psychopathology. Child Adolesc Psychiatr Clin N Am 2010; 19(3): 609-23.
148. Kay-Lambkin FJ, Baker AL, Kelly B, Lewin TJ. Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: A randomised controlled trial. Med J Aust 2011; 195(3 SUPPL): S44-S50.
149. Henderson CE, Dakof GA, Greenbaum PE, Liddle HA. Effectiveness of Multidimensional Family Therapy with higher severity substance-abusing adolescents: Report from two randomized controlled trials. J Consult Clin Psychol 2010; 78(6): 885-97.
150. Liddle HA, Rowe CL, Dakof GA, Henderson CE, Greenbaum PE. Multidimensional family therapy for young adolescent substance abuse: twelve-month outcomes of a randomized controlled trial. J Consult Clin Psychol 2009; 77: 12-25.
151. Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M. Multidimensional family therapy for adolescent substance abuse: Results of a randomized clinical trial. Am J Drug Alcohol Abuse 2001; 27: 651-8.
152. Liddle HA, Rowe CL, Dakof GA, Ungaro RA, Henderson CE. Early intervention for adolescent substance abuse: Pretreatment to posttreatment outcomes of a randomized controlled trial comparing multidimensional family therapy and peer group treatment. J Psychoactive Drugs 2004; 36(1): 2-37.
153. Liddle HA, Dakof GA, Turner RM, Henderson CE, Greenbaum PE. Treating adolescent drug abuse: a randomized trial comparing multidimensional family therapy and cognitive behavior therapy. Addiction 2008; 103(10): 1660-70.
154. Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry 2002; 41(7): 868-74.
155. Henggeler SW, Pickrel S, Brondino M. Multisystemic treatment of substance abusing and dependent delinquents: outcomes, treatment fidelity, and transportability. Ment Health Serv Res 1999; 1: 171-84.
156. [156] Timmons-Mitchell J, Bender MB, Kishna MA, Mitchell CC. An independent effectiveness trial of Multisystemic Therapy with juvenile justice youth. J Clin Child Adolesc Psychol 2006; 35(2): 227-36.
157. [157] Dickersin K, Chan S, Chalmers T, Sacks H, Smith HJ. Publication bias and clinical trials. Control Clin Trials 1987; 8(4): 343-53.
158. [158] Easterbrook P, Berlin J, Gopalan R, Matthews D. Publication bias in clinical research. Lancet 1991; 337(8746): 867-72.
159. [159] Dwan K, Altman D, Arnaiz J, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008; 3(8): e3081.
160. [160] Barker G, Olukoya A, Aggleton P. Young people, social support and help-seeking. Int J Adolesc Med Health 2005; 17: 315-35.
161. [161] Preziosa A, Grassi A, Gaggioli A, Riva G. Therapeutic applications of the mobile phone. Brit J Guid Couns 2009; 37: 313-25.
162. [162] Deady M, Kay-Lambkin F, Thornton L, Baker A, Teesson M. Social Influence, Addictions and the Internet: The potential of Web 2.0 technologies in enhancing treatment for alcohol/other drug use problems. J Addict Res Ther 2012; S8.
163. [163] Griffiths KM, Christensen H. Review of randomised controlled trials of Internet interventions for mental disorders and related conditions. Clin Psychol 2006; 10(1): 16-29.
164. [164] Ybarra ML, Eaton WW. Internet-based mental health interventions. Ment Health Serv Res 2005; 7(2): 75-87.
165. [165] Merry SN, Stasiak K, Shepherd M, Frampton C, Fleming T, Lucassen MFG. The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. Br Med J 2012; 344: e2598
166. [166] Shandley K, Austin D, Klein B, Kyrios M. An evaluation of ‘Reach Out Central’: an online gaming program for supporting the mental health of young people. Health Educ Res 2010; 25(4): 563-74.
167. [167] Burns J, Rapee RM. Adolescent mental health literacy: young people’s knowledge of depression and help seeking. J Adolesc 2006; 29: 225-39.
168. [168] Nicholas J, Oliver K, Lee K, O’Brien M. Help-seeking behavior on the Internet: An investigation among Australian adolescents. AeJAMH 2004; 3: 1-8.
169. [169] Burns J, Durkin LA, Nicholas J. Mental health of young people in the United States: What role can the internet play in reducing stigma and promoting help seeking? J Adolesc Health 2009; 45(1): 95-7.